Compound Detail
CHEMBL1724
MEPENZOLATE BROMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1724 |
| Name | MEPENZOLATE BROMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | JRRNZNSGDSFFIR-UHFFFAOYSA-M |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL524004 |
| Active Moiety | CHEMBL524004 |
3
Targets
5
Activities
2
Assay Types
0
PK Parameters
20
Publications
8
Known Names
2
Mechanisms
Molecular Properties
340.4
MW (Da)
2.70
ALogP
3
HBA
1
HBD
46.5
PSA (Ų)
0.69
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1956 |
| Availability | Discontinued |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Muscarinic acetylcholine receptor M3 antagonist | ANTAGONIST | Muscarinic acetylcholine receptor M3 | ✓ | ✓ |
| Muscarinic acetylcholine receptor M1 antagonist | ANTAGONIST | Muscarinic acetylcholine receptor M1 | ✓ | ✓ |
Activity Summary
Ki 4 meas. best 9.17
IC50 1 meas. best 4.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 9.17 | 8.925 | 0.7 | 2 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 8.59 | 8.435 | 2.6 | 2 |
| Solute carrier family 22 member 1 CHEMBL5685 | IC50 | 4.19 | 4.19 | 64900.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 24844758 | 10.1016/j.bmc.2014.04.029 | Mus musculus | 10 |
| 31204225 | 10.1016/j.bmc.2019.06.016 | Mus musculus | 4 |
| - | 10.6019/CHEMBL4513161 | Pseudomonas aeruginosa | 2 |
| 24844758 | 10.1016/j.bmc.2014.04.029 | Muscarinic acetylcholine receptor M2 | 2 |
| 18788725 | 10.1021/jm8003152 | Solute carrier family 22 member 1 | 2 |
| 31204225 | 10.1016/j.bmc.2019.06.016 | Muscarinic acetylcholine receptor M3 | 1 |
| - | 10.6019/CHEMBL4513161 | HEK293 | 1 |
| - | 10.6019/CHEMBL4513141 | Acinetobacter baumannii | 1 |
| - | 10.6019/CHEMBL4513141 | Pseudomonas aeruginosa | 1 |
| - | 10.6019/CHEMBL4513141 | Klebsiella pneumoniae | 1 |
| - | 10.6019/CHEMBL4513141 | Escherichia coli | 1 |
| - | 10.6019/CHEMBL4513141 | Cryptococcus neoformans | 1 |
| - | 10.6019/CHEMBL4513141 | Candida albicans | 1 |
| 31204225 | 10.1016/j.bmc.2019.06.016 | Muscarinic acetylcholine receptor M2 | 1 |
| - | 10.1101/2020.04.03.023846 | SARS-CoV-2 | 1 |
| 22961681 | 10.1124/dmd.112.047068 | Bile salt export pump | 1 |
| 24844758 | 10.1016/j.bmc.2014.04.029 | Muscarinic acetylcholine receptor M3 | 1 |
| 23571415 | 10.1124/mol.112.084152 | Solute carrier organic anion transporter family member 1B3 | 1 |
| 23571415 | 10.1124/mol.112.084152 | Solute carrier organic anion transporter family member 1B1 | 1 |
Data from ChEMBL 36 via Core Engine